Growth hormone replacement in healthy older men improves body composition but not functional ability

Annals of Internal Medicine

Volumn 124, Issue 8, 1996, Pages 708-716

  Papadakis, Maxine A ^b   Grady, Deborah ^b   Black, Dennis ^b   Tierney, Mary Jo ^b   Gooding, Gretchen A W ^b   Schambelan, Morris ^b   Grunfeld, Carl ^b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE; HUMAN GROWTH HORMONE; HYDROCORTISONE; SOMATOMEDIN C;

AGED; AGING; ANGINA PECTORIS; ARTHRALGIA; ARTICLE; BODY FAT; CLINICAL TRIAL; COGNITION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; ENDURANCE; FUNCTIONAL ASSESSMENT; GROWTH HORMONE RELEASE; GYNECOMASTIA; HEART INFARCTION; HORMONE SUBSTITUTION; HUMAN; LEAN BODY WEIGHT; LEG EDEMA; MALAISE; MALE; MOOD; MUSCLE STRENGTH; NORMAL HUMAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0029993686     PISSN: 00034819     EISSN: None     Source Type: Journal    
DOI: 10.7326/0003-4819-124-8-199604150-00002     Document Type: Article

References (38)

1. Rudman D. Growth hormone, body composition, and aging J Am Geriatr Soc 1985;33:800-7
2. Novak LP. Aging, total body potassium, fat-free mass, and cell mass in males and females between ages 18 and 85 years J Gerontol 1972,27.438-43
3. Vandervoot AA, Hayes KC, Belanger AY. Strength and endurance of skeletal muscle in the elderly Physiotherapy Canada 1986,38:167-73
4. Dry MG, Schechtman KB, Miller JP, Hadley EC, Fiatarone MA, Province MA, et al. Frailty and injuries in later life, the FICSIT trials J Am Geriatr Soc 1993;41:283-96.
5. Tinnetti ME, Williams TF, Mayewski R. Fall risk index for elderly patients based on the number of chronic disabilities Am J Med 1986,80:429-34
6. Wolfson L. Quantitative assessment of neuromuscular factors involved in falling elderly In: Biological and Behavioral Aspects of Falls in the Elderly Proceedings of a Conference Sponsored by the National Institute on Aging. September 1984; 17-8
7. Rudman D, Kutner MH, Rogers CM, Lubin MF, Fleming GA, Bain RP. Impaired growth hormone secretion in the adult population: relation to age and adiposity J Clin Invest 1981,67 1361-9
8. Flaim KE, Li JB, Jefferson LS. Protein turnover in rat skeletal muscle: effects of hypophysectomy and growth hormone Am J Physiol. 1978;234.E38-E43
9. Beck JC. Primate growth hormone studies in man Metabolism. 1960,9.699-737
10. Bergenstal DM, Lipsett MB. Metabolic effects of human growth hormone and growth hormone of other species in man J Clin Endocrinol Metab 1960;20:1427-36
11. Corpas E, Harman SM, Blackman MR. Human growth hormone and human aging. Endocr Rev. 1993;14:20-39.
12. Jorgensen JO, Pedersen SA, Thuesen L, Jorgensen J, Ingemann-Hansen T, Skakkebaek NE, et al. Beneficial effects of growth hormone treatment in GH-deficient adults. Lancet 1989,1 1221-5.
13. Salomon R, Cuneo RC, Hesp R, Sonksen PH. The effects of treatment with recombinant human growth hormone on body composition and metabolism in adults with growth hormone deficiency N Engl J Med 1989,321 1797-803
14. Rudman D, Feller AG, Nagraj HS, Gergans G, Lalitha P, Goldberg AF, et al. Effects of human growth hormone in men over 60 years old N Engl J Med 1990,323 1-9
15. Ho KY, Evans WS, Blizzard RM, Veldhuis JD, Merriam GR, Samojlik E, et al. Effects of sex and age on the 24-hour profile of growth hormone secretion in man importance of endogenous estradiol concentrations. J Clin Endocrinol Metab 1987,64:51-8
16. Vermeulen A. Nyctohemeral growth hormone profiles in young and aged men correlation with somatamedin-C levels. J Clin Endocrinol Metab 1987, 64 884-8
17. Chatelain PG, Van Wyk J, Copeland KC, Blethen SL, Underwood LE. Effect of in vitro action of serum protease or exposure to acid on measurable immunoreactive somatomedin-C in serum. J Clin Endocrinol Metab 1983,56: 376-83.
18. Frisancho AR. New standards of weight and body composition by frame size and height for assessment of nutritional status of adults and the elderly Am J Clin Nutr 1984;40 808-19.
19. Reuben DB, Siu AL. An objective measure of physical function of elderly outpatients The Physical Performance Test. J Am Geriatr Soc 1990,38 1105-12
20. Reitan R. Validity of the trail-making test as an indicator of organic brain disease Perceptual and Motor Skills. 1958;8:271-6
21. Folstein MF, Folstein SE, McHugh PR. Mini-mental State. A practical method for grading the cognitive state of patients for the clinician J Psychiatr Res 1975;12 189-98.
22. Salthouse TA. What do adult age differences in the Digit Symbol Substitution Test reflect? J Gerontol 1992;47 P121-8.
23. Sheikh JI, Yesavage JA. Geriatric Depression Scale: Recent evidence and development of a shorter version Clin Gerontol 1986,5 165-72
24. Draper NR, Smith J. Applied Regression Analysis New York. John Wiley, 1966
25. Papadakis MA, Grady D, Tierney MJ, Black D, Wells L, Grunfeld C. Insulin-like growth factor 1 and functional status in healthy older men J Am Geriatr Soc 1996;43 1350-5
26. Fiatarone MA, O'Neill EF, Ryan ND, Clements KM, Solares GR, Nelson ME, et al. Exercise training and nutritional supplementation for physical frailty in very elderly people. N Engl J Med. 1994,330 1769-75.
27. Pyka G, Lindenberger E, Charette S, Marcus R. Muscle strength and fiber adaptations to a year-long resistance training program in elderly men and women J Gerontol 1994;49 M22-7
28. Taaffe DR, Pruitt L, Reim J, Hintz RL, Butterfield G, Hoffman AR, et al. Effect of recombinant human growth hormone on the muscle strength response to resistance exercise in elderly men J Clin Endocrinol Metab. 1994, 79:1361-6.
29. Holloway L, Butterfield G, Hintz RL, Gesundheit N, Marcus R. Effects of recombinant human growth hormone on metabolic indices, body composition, and bone turnover in healthy elderly women J Clin Endocrinol Metab. 1994,79.470-9
30. Thompson JL, Butterfield GE, Marcus R, Hintz RL, Van Loan M, Ghiron L, et al. The effects of recombinant human insulin-like growth factor-I and growth hormone on body composition in elderly women J Clin Endocrinol Metab. 1995,80.1845-52
31. Mulligan K, Grunfeld C, Hellerstein MK, Neese RA, Schambelan M. Anabolic effects of recombinant human growth hormone in patients with wasting associated with human immunodeficiency virus infection. J Clin Endocrinol Metab 1993,77:956-62
32. Ziegler TR, Barbieri RL, Young LS, Ferrari-Baliviera E, Wilmore DW. Effects of growth hormone administration on dehydroepiandrosterone sulphate, androstenedione, testosterone and cortisol metabolism during nutritional repletion Clin Endocrinol (Oxf) 1991;34:281-7
33. Clemmons DR, Van Wyk JJ. Factors controlling blood concentration of somatomedin C Clin Endocrinol Metab 1984,13 113-43.
34. Poehlman ET, Copeland KC. Influence of physical activity on insulin-like growth factor-I in healthy younger and older men J Clin Endocrinol Metabol 1990;71:1468-73
35. Copeland KC, Colletti RB, Devlin JT, McAuliffe TL. The relationship between insulin-like growth factor-I, adiposity, and aging Metabolism 1990, 39:584-7
36. Hoffman DM, O'Sullivan AJ, Baxter RC, Ho KK. Diagnosis of growth-hormone deficiency in adults Lancet 1994,343 1064-8
37. Cuneo RC, Salomon F, Wiles CM, Hesp R, Sonksen PH. Growth hormone treatment in growth hormone-deficient adults II. Effects on exercise performance J Appl Physiol 1991,70 695-700.
38. Jorgensen JO, Thuesen L, Muller J, Ovesen P, Skakkebaek NE, Christiansen JS. Three years of growth hormone treatment in growth hormone-deficient adults near normalization of body composition and physical performance. Eur J Endocrinol. 1994;130 224-8